Showing results (181-190 of 196) with videos related to
Sort By:
Pageof 20
European Journal of Clinical Pharmacology|January 1, 1990
Pharmacokinetics and pharmacodynamics of the ace inhibitor benazepril hydrochloride in the elderlyG Kaiser, R Ackermann, W Dieterle, et al.British Journal of Clinical Pharmacology|August 1, 1997
Single and multiple dose pharmacokinetics of felbamate in the elderlyA Richens, C R Banfield, M Salfi, et al.Annals of Clinical Biochemistry|May 1, 1990
A survey of drugs of abuse testing by clinical laboratories in the United Kingdom. Steering Committee for the UK-External Quality Assessment Scheme for Therapeutic Drug AssaysD Burnett, S Lader, A Richens, et al.British Journal of Clinical Pharmacology|October 1, 1987
Oral phenytoin pharmacokinetics during omeprazole therapyP J Prichard, R P Walt, G K Kitchingman, et al.Gut|February 1, 1987
Metabolism and urinary excretion of 5-amino salicylic acid in healthy volunteers when given intravenously or released for absorption at different sites in the gastrointestinal tractB Myers, D N Evans, J Rhodes, et al.British Journal of Clinical Pharmacology|December 1, 1993
Vigabatrin-induced decrease in serum phenytoin concentration does not involve a change in phenytoin bioavailabilityG Gatti, A Bartoli, R Marchiselli, et al.Electroencephalography and Clinical Neurophysiology|April 1, 1989
A study of inter-reviewer reliability of attacks recorded on ambulatory EEGS J Wroe, T E Powell, I Smith, et al.Epilepsy Research|May 1, 1995
Adjunctive treatment of partial seizures with tiagabine: a placebo-controlled trialA Richens, D W Chadwick, J S Duncan, et al.Clinical Pharmacology and Therapeutics|October 1, 1991
The influence of age on the pharmacokinetics of the antiepileptic agent oxcarbazepineP N van Heiningen, M D Eve, B Oosterhuis, et al.Clinical Pharmacokinetics|July 1, 1983
Steady-state pharmacokinetics of phenytoin from routinely collected patient dataT H Grasela, L B Sheiner, B Rambeck, et al.Pageof 20